Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis.

This review has sought to demonstrate that eosinophils have an important role in the immunopathology of onchocercal dermatitis and keratitis. The most compelling evidence is the consistent presence of eosinophils and eosinophil granule proteins at the site of tissue damage, either after parasite death or direct injection of parasite antigens. A more definitive role for eosinophils in onchocercal keratitis will be determined using IL-5 gene knockout mice (an animal model of onchocercal dermatitis has yet to be established). Identification of chemoattractants and adhesion molecules necessary for eosinophil recruitment will indicate possible approaches to immune intervention.

[1]  J. Kazura,et al.  Pleomorphism of stromal eosinophils in murine experimental onchocercal keratitis. , 1997, Ocular immunology and inflammation.

[2]  J. Kazura,et al.  IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression. , 1997, Journal of Immunology.

[3]  D. Freedman,et al.  Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen. , 1996, The Journal of infectious diseases.

[4]  E. Pearlman.  Experimental onchocercal keratitis. , 1996, Parasitology today.

[5]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[6]  J. Kazura,et al.  Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness) , 1995, The Journal of experimental medicine.

[7]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[8]  H. Kita,et al.  Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. , 1995, Journal of immunology.

[9]  E. Ottesen.  Immune responsiveness and the pathogenesis of human onchocerciasis. , 1995, The Journal of infectious diseases.

[10]  T. Nutman,et al.  Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. , 1995, The Journal of infectious diseases.

[11]  J. McCarthy,et al.  Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. , 1994, The Journal of infectious diseases.

[12]  P. Debré,et al.  Involvement of FcϵRII/CD23 and L-Arginine Dependent Pathway in IgE-Mediated Activation of Human Eosinophils , 1994 .

[13]  P. Scott,et al.  IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. , 1994, Journal of immunology.

[14]  J. Zieske,et al.  Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. , 1994, Investigative ophthalmology & visual science.

[15]  M. Taylor,et al.  Protective immunity against Onchocerca volvulus and O. lienalis infective larvae in mice. , 1994, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[16]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[17]  A. Capron,et al.  High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.

[18]  T. Williams,et al.  The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. , 1993, Biochemical and biophysical research communications.

[19]  C. Heusser,et al.  Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. , 1993, The Journal of laboratory and clinical medicine.

[20]  J. Abrams,et al.  IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. , 1993, Journal of immunology.

[21]  D. Chakravarti,et al.  Immune-mediated Onchocerca volvulus sclerosing keratitis in the mouse. , 1993, Experimental eye research.

[22]  T. Nutman,et al.  Regulation of IL-5 in onchocerciasis. A critical role for IL-2. , 1993, Journal of immunology.

[23]  B. Duke.  The population dynamics of Onchocerca volvulus in the human host. , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[24]  J. Abrams,et al.  Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. , 1993, The Journal of infectious diseases.

[25]  P. Weller,et al.  Mechanisms of eosinophil recruitment. , 1993, American journal of respiratory cell and molecular biology.

[26]  J. Fehr,et al.  IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. , 1992, Journal of immunology.

[27]  E. Ottesen,et al.  The Wellcome Trust Lecture: Infection and disease in lymphatic filariasis: an immunological perspective , 1992, Parasitology.

[28]  J. Abrams,et al.  Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. , 1991, The Journal of clinical investigation.

[29]  A. Capron,et al.  Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. , 1991, The Journal of allergy and clinical immunology.

[30]  S. Goelz,et al.  Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Weller,et al.  The immunobiology of eosinophils. , 1991, The New England journal of medicine.

[32]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[33]  C. Wheatley,et al.  Activation of platelets by eosinophil granule proteins , 1990, The Journal of experimental medicine.

[34]  A. Limaye,et al.  Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients , 1990, The Journal of experimental medicine.

[35]  G. Gleich,et al.  Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. , 1990, Journal of immunology.

[36]  R. Coffman,et al.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. , 1989, Science.

[37]  H. Grossniklaus,et al.  Experimental interstitial keratitis induced by Onchocerca volvulus antigens. , 1988, Archives of ophthalmology.

[38]  W. Paul,et al.  Regulation of IgG1 and IgE Production by Interleukin 4 , 1988, Immunological reviews.

[39]  J. Ellner,et al.  Cell-mediated immune responses in human infection with Onchocerca volvulus. , 1988, Journal of immunology.

[40]  J. Donnelly,et al.  Punctate keratitis induced by subconjunctivally injected microfilariae of Onchocerca lienalis. , 1986, Archives of ophthalmology.

[41]  E. Ottesen.  Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis. , 1985, Reviews of infectious diseases.

[42]  D. W. Gibson,et al.  Pathologic changes of human onchocerciasis: implications for future research. , 1985, Reviews of infectious diseases.

[43]  J. Donnelly,et al.  Onchocerciasis: experimental models of ocular disease. , 1985, Reviews of infectious diseases.

[44]  A. Gbakima,et al.  Humoral and cellular immune responses to Onchocerca volvulus infection in humans. , 1985, Reviews of infectious diseases.

[45]  M. Steward,et al.  Variations in host responses and the pathogenesis of human onchocerciasis. , 1985, Reviews of infectious diseases.

[46]  R. Murphy,et al.  Chorioretinal damage in onchocerciasis. , 1984, American journal of ophthalmology.

[47]  J. Donnelly,et al.  Ocular immunopathologic findings of experimental onchocerciasis. , 1984, Archives of ophthalmology.

[48]  B. Duke,et al.  A comparison of the lesions produced in the cornea of the rabbit eye by microfilariae of the forest and Sudan-savanna strains of Onchocerca volvulus from Cameroon. I. The clinical picture. , 1972, Zeitschrift fur Tropenmedizin und Parasitologie.

[49]  F. C. Rodger.  The pathogenesis and pathology of ocular onchocerciasis. , 1960, American journal of ophthalmology.

[50]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[51]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[52]  G. Gleich,et al.  The biology of the eosinophilic leukocyte. , 1993, Annual review of medicine.

[53]  R. Nussenblatt,et al.  Immunopathology of ocular onchocerciasis 3. Th-2 helper T cells in the conjunctiva. , 1993, Ocular immunology and inflammation.

[54]  G. Gleich,et al.  Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[55]  J. Donnelly,et al.  Aqueous humor and serum IgE antibody in experimental ocular Onchocerca infection of guinea pigs. , 1983, Ophthalmic research.

[56]  A. Garner.  Pathology of ocular onchocerciasis: human and experimental. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.